Rosalind Advisors, Inc.
Top Portfolio Positions
32 positions ·
$244,512,536 total
· as of Mar 31, 2026
| Ticker | Company | Shares | Value (USD) | % of Portfolio | Open |
|---|---|---|---|---|---|
| DCTH |
Delcath Systems, Inc.
Healthcare
|
3,300,389 | $30,627,609 | 12.53% | |
| XERS |
Xeris Biopharma Holdings, Inc.
Healthcare
|
3,231,700 | $18,743,860 | 7.67% | |
| FENC |
Fennec Pharmaceuticals Inc.
Healthcare
|
2,908,201 | $17,885,436 | 7.31% | |
| SVRA |
Savara Inc
Healthcare
|
3,203,721 | $17,492,316 | 7.15% | |
| PCVX |
Vaxcyte, Inc.
Healthcare
|
290,000 | $16,851,900 | 6.89% | |
| EYPT |
EyePoint, Inc.
Healthcare
|
1,036,737 | $13,363,539 | 5.47% | |
| XFOR |
X4 Pharmaceuticals, Inc
Healthcare
|
3,214,766 | $13,276,983 | 5.43% | |
| VOR |
Vor Biopharma Inc.
Healthcare
|
700,000 | $12,488,000 | 5.11% | |
| MDWD |
MediWound Ltd.
Healthcare
|
749,054 | $12,067,259 | 4.94% | |
| VSTM |
Verastem, Inc.
Healthcare
|
2,138,475 | $11,333,917 | 4.64% |
Portfolio Trend
Holdings in NSPR
Shares Held
Position Value (USD)
10 quarters on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $6,366,361 | 3,905,743 | Shares | Sole | 2026-05-14 | |
| 2025-12-31 | $6,952,222 | 3,905,743 | Shares | Sole | 2026-02-12 | |
| 2025-09-30 | $9,412,840 | 3,905,743 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $5,196,254 | 2,289,099 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $6,119,723 | 2,274,990 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $6,563,909 | 2,495,783 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $6,737,643 | 2,514,046 | Shares | Sole | 2024-10-30 | |
| 2024-06-30 | $6,284,102 | 2,513,641 | Shares | Sole | 2024-07-12 | |
| 2024-03-31 | $1,625,966 | 686,062 | Shares | Sole | 2024-04-25 | |
| 2023-12-31 | $2,599,795 | 925,194 | Shares | Sole | 2024-02-14 | |
| No 13F history on record for this holder in this stock. | ||||||